PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Macarthy's Laboratories Ltd T/A Martindale Pharma
ML

Macarthy's Laboratories Ltd T/A Martindale Pharma

Romford
Large

Ethypharm is a leading mid-size international specialty pharmaceutical company that manufactures and provides essential medicines, focusing on Central Nervous System (CNS) and Hospital Injectables.

ethypharm.com ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£1.0bn
Live
11
Buyers
5
12m
£991.5m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts11 / 17
  • Top buyers5
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Macarthy's Laboratories Ltd T/A Martindale PharmaUpdated 06 Jul 2026

At a glance · for buyers and watchdogs

Macarthy's Laboratories Ltd T/A Martindale Pharma has won £1.0bn across 5 public-sector buyers, with 11 live contracts. No active Companies House risk flags.

Why: top buyer NHS England at 99% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
11 of 17Live contracts
99%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Sectors served · 1/8
Central government✓
Local government✓
NHS & health✓
Housing✓
Utilities & energy✓
Financial services✓
Education✓
Defence✓
Services · 2
Central Nervous System (CNS)Ethypharm develops medicines for the treatment of severe pain and addiction. ↗Hospital InjectablesEthypharm provides injectable solutions for critical care situations. ↗

Extracted automatically from ethypharm.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies · 2

Delivery stories from the supplier’s website. Clients are not yet cross-checked against award records.

◐ From supplier website
Ethypharm Iberia adds Nefopam to its portfolioEthypharm Iberia has signed a licensing agreement to commercialize Nefopam HCl 20mg/2ml injectable solution in Spain, addressing a need for additional therapeutic options for moderate to severe pain. ↗Recivit® returns to Ethypharm’s portfolio in FranceEthypharm has taken back the distribution of Recivit® (fentanyl), a treatment for severe pain, reinforcing its commitment to pain management. ↗

Extracted automatically from ethypharm.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 11 live · 6 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS National Generics Pharmaceuticals - Supply Chain Resilience
NHS England—01 Sept 2026£35.0m1.8 yrspending
NHS National Branded Interim - 1 June 2026
NHS England—01 Jun 2026£529.1m1.9 yrspending
Generic Drugs – Injections/Infusions 2
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)—01 Jul 2026£5.9m12 mopending
NHS National Generic Pharmaceuticals - Wave 15c
NHS England—01 Jun 2026£403.7m2 yrspending
NHS National Framework for Generics Housekeeping
NHS England—01 Feb 2026£17.8m12 mopending
NHS Framework Agreement for Branded Medicines - National
NHS England3360000001 May 2019£18.5m2 yrsClosed
NHS National Generic Pharmaceuticals - Wave 15c
NHS England————Live
Generic, Branded Generic & Proprietary Medicinal Products - Group 17
Procurement and Logistics Service, Business Services Organisation————Live
NHS National Framework for Generics Housekeeping
NHS England————Live
NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025
NHS England33600000———Live
Total live value — · mean award £59.4m1–10 of 17

Top buyers · 5 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
10 contracts
99%
since 2019
2
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
1 contract
1%
since 2026
3
Procurement and Logistics Service, Business Services Organisation
2 contracts
0%
4
Regional Business Services Organisation Procurement and Logistics Service
1 contract
0%
5
Procurement and Logistics Service
3 contracts
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire10 contracts
99%
Wales1 contract
1%
Northern Ireland6 contracts
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Macarthy's Laboratories Ltd T/A Martindale Pharma highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
ML
Macarthy's Laboratories Ltd T/A Martindale Pharma
No£991.5m—
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m22
JA
Janssen-Cilag Ltd
Yes£117.6m18
AB
AbbVie Ltd
Yes£95.2m12
TA
Thornton and Ross Ltd
Yes£72.5m12
AC
ACCORD-UK LTD
Yes£71.2m21
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Dec 2024
Confirmation statement
Up to date
Next due 08 Nov 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
00620024
Status
Active
Type
Private limited
Incorporated
30 Jan 1959
Reg. office
Bampton Road, Harold Hill, Romford, Essex, RM3 8UG
SIC codes
21100
Last accounts
31 Dec 2024
Next accounts due
30 Sept 2026

Directors & PSC

  • MEHRAI, Alexander — director
    Appointed 31 Jan 2025
  • RUYANT, Foucauld — secretary
    Appointed 30 Sept 2024
  • RUYANT, Foucauld — director
    Appointed 30 Sept 2024
  • LASSERRE, Xavier Pierre Christian — director
    Appointed 26 Jun 2023
  • DE ULTRA DE SOUSA BARCELOS, Bruno — director
    Appointed 17 Jan 2023
  • Orphea Limited — person with significant control
    ownership of shares 75 to 100 percent · voting rights 75 to 100 percent · right to appoint and remove directors

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
MACARTHYS LABORATORIES LIMITED
00620024 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.